[1] |
Azarbarzin A, Labarca G, Kwon Y, et al. Physiological consequences of upper airway obstruction in sleep apnea[J]. Chest, 2024, 166:1209-1217. doi: 10.1016/j.chest.2024.05.028.
|
[2] |
Cortese R, Adams TS, Cataldo KH, et al. Single-cell RNA-seq uncovers cellular heterogeneity and provides a signature for paediatric sleep apnoea[J]. Eur Respir J, 2023, 61:2201465. doi: 10.1183/13993003.01465-2022.
|
[3] |
Zhang X, Zhang H, Li S, et al. Recent progresses in gut microbiome mediates obstructive sleep apnea-induced cardiovascular diseases[J]. FASEB Bioadv, 2024, 6: 118-130. doi: 10.1096/fba.2023-00153.
|
[4] |
Bowers SJ, Vargas F, González A, et al. Repeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome[J]. PLoS One, 2020, 15: e0229001. doi: 10.1371/journal.pone.0229001.
|
[5] |
Li Q, Xu T, Shao C, et al. Obstructive sleep apnea is related to alterations in fecal microbiome and impaired intestinal barrier function[J]. Sci Rep, 2023, 13: 778. doi: 10.1038/s41598-023-27784-0.
|
[6] |
Liu D, Meng H, Wan N, et al. Association of CLDN molecules with sleep apnea hypopnea syndrome: new biomarker candidates[J]. Front Neurol, 2024, 15: 1347137. doi: 10.3389/fneur.2024.1347137.
|
[7] |
Kadier K, Dilixiati D, Ainiwaer A, et al. Analysis of the relationship between sleep-related disorder and systemic immune-inflammation index in the US population[J]. BMC Psychiatry, 2023, 23: 773. doi: 10.1186/s12888-023-05286-7.
|
[8] |
Polasky C, Steffen A, Loyal K, et al. Redistribution of monocyte subsets in obstructive sleep apnea syndrome patients leads to an imbalanced PD-1/PD-L1 cross-talk with CD4/CD8 T cells[J]. J Immunol, 2021, 206: 51-58. doi: 10.4049/jimmunol.2001047.
|
[9] |
Farahi L, Sinha SK, Lusis AJ. Roles of macrophages in atherogenesis[J]. Front Pharmacol, 2021, 12: 785220. doi: 10.3389/fphar.2021.785220.
|
[10] |
Domagała-Kulawik J, Osińska I, Piechuta A, et al. T, B, and NKT cells in systemic inflammation in obstructive sleep apnoea[J]. Mediators Inflamm, 2015, 2015: 161579. doi: 10.1155/2015/161579.
|
[11] |
Gaoatswe G, Kent BD, Corrigan MA, et al. Invariant natural killer T cell deficiency and functional impair-ment in sleep apnea: links to cancer comorbidity[J]. Sleep, 2015, 38: 1629-1634. doi: 10.5665/sleep.5062.
|
[12] |
Galati D, Zanotta S, Canora A, et al. Severe depletion of peripheral blood dendritic cell subsets in obstructive sleep apnea patients: A new link with cancer?[J]. Cytokine, 2020, 125: 154831. doi: 10.1016/j.cyto.2019.154831.
|
[13] |
Xu YD, Cheng M, Shang PP, et al. Role of IL-6 in dendritic cell functions[J]. J Leukoc Biol, 2022, 111: 695-709. doi: 10.1002/jlb.3mr0621-616rr.
|
[14] |
Xie H, Yin J, Bai Y, et al. Differential expression of immune markers in the patients with obstructive sleep apnea/hypopnea syndrome[J]. Eur Arch Otorhinol-aryngol, 2019, 276: 735-744. doi: 10.1007/s00405-018-5219-6.
|
[15] |
Cubillos-Zapata C, Avendaño-Ortiz J, Hernandez-Jimenez E, et al. Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea[J]. Eur Respir J, 2017, 50:1700833. doi: 10.1183/13993003.00833-2017.
|
[16] |
Díaz-García E, García-Sánchez A, Alfaro E, et al. PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea[J]. Front Immunol, 2023, 14: 1277551. doi: 10.3389/fimmu.2023.1277551.
|
[17] |
章哪哪, 李艳妮, 李本农,等. 外周血Th17细胞与OSA患者颈动脉内-中膜厚度的相关性[J]临床耳鼻咽喉头颈外科杂志, 2020, 34:747-751.
|
[18] |
Borker PV, Patel SR. Monocyte activation: the link between obstructive sleep apnea and cardiovascular disease?[J]. Am J Respir Crit Care Med, 2022, 205: 1268-1270. doi: 10.1164/rccm.202201-0215ED.
|
[19] |
Mok EM, Greenough G, Pollack CC. Untreated obstruc-tive sleep apnea is associated with increased hospitaliza-tion from influenza infection[J]. J Clin Sleep Med, 2020, 16: 2003-2007. doi: 10.5664/jcsm.8744.
|
[20] |
Quan SF, Weaver MD, Czeisler M, et al. Associations between obstructive sleep apnea and COVID-19 infection and hospitalization among US adults[J]. J Clin Sleep Med, 2023, 19: 1303-1311. doi: 10.5664/jcsm.10588.
|
[21] |
Cao Y, Ning P, Li Q, et al. Cancer and obstructive sleep apnea: an updated meta-analysis[J]. Medicine (Baltimore), 2022, 101: e28930. doi: 10.1097/md.0000000000028930.
|
[22] |
Palm A, Theorell-Haglöw J, Isakson J, et al. Associa-tion between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort[J]. BMJ Open, 2023, 13: e064501. doi: 10.1136/bmjopen-2022-064501.
|
[23] |
Cubillos-Zapata C, Troncoso-Acevedo F, Díaz-García E, et al. Sleep apnoea increases biomarkers of immune evasion, lymphangiogenesis and tumour cell aggressiveness in high-risk patients and those with established lung cancer[J]. ERJ Open Res, 2024, 10:00777-2023. doi: 10.1183/23120541.00777-2023.
|
[24] |
Díaz-García E, García-Sánchez A, Sánz-Rubio D, et al. SMAD4 expression in monocytes as a potential biomarker for atherosclerosis risk in patients with obstructive sleep apnea[J]. Int J Mol Sci, 2023, 24:7900. doi: 10.3390/ijms24097900.
|
[25] |
Ambati A, Ju YE, Lin L, et al. Proteomic biomarkers of sleep apnea[J]. Sleep, 2020, 43:zsaa086. doi: 10.1093/sleep/zsaa086.
|